The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Caspofungin 50mg powder for concentrate for solution for infusion

Flynn Pharma LimitedPA1226/013/001

Main Information

Trade NameCaspofungin 50mg powder for concentrate for solution for infusion
Active SubstancesCaspofungin
Dosage FormPowder for concentrate for solution for infusion
Licence HolderFlynn Pharma Limited
Licence NumberPA1226/013/001

Group Information

ATC CodeJ02AX Other antimycotics for systemic use
J02AX04 caspofungin


License statusAuthorised
Licence Issued13/01/2017
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back